Takeshi Kawakami

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Metastatic Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

This page only lists publications with an associated author ORCID identifier.

Publications

Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto, Hiasto Kawakami, Takashi Oshima, Kensei Yamaguchi, Kaori Hino, Motohiro Hirao, Yukinori Kurokawa, Takeshi Kawakami, Masahiro Tsuda, Hiroki Hara, Shota Kaname, Daiko Matsuoka, Yohei Otake, Keisuke Yasuda, Takao Takase, Shuya Takashima, Taro Semba, Kei Muro
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto, Hiasto Kawakami, Takashi Oshima, Kensei Yamaguchi, Kaori Hino, Motohiro Hirao, Yukinori Kurokawa, Takeshi Kawakami, Masahiro Tsuda, Hiroki Hara, Shota Kaname, Daiko Matsuoka, Yohei Otake, Keisuke Yasuda, Takao Takase, Shuya Takashima, Taro Semba, Kei Muro
Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Takeshi Kawakami, Kentaro Yamazaki
Recent Progress in Treatment for HER2-Positive Advanced Gastric Cancer. Cancers 16 (9) (2024)
Takeshi Kawakami, Kentaro Yamazaki
Recent Progress in Treatment for HER2-Positive Advanced Gastric Cancer. Cancers 16 (9) (2024)
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui, Kentaro Yamazaki
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin. BMC cancer 23 (1) (2023)
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui, Kentaro Yamazaki
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin. BMC cancer 23 (1) (2023)
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui, Kentaro Yamazaki
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin. BMC cancer 23 (1) (2023)
Takeshi Kawakami, Akiko Todaka, Kotoe Oshima, Kunihiro Fushiki, Satoshi Hamauchi, Takahiro Tsushima, Tomoya Yokota, Yusuke Onozawa, Hirofumi Yasui, Kentaro Yamazaki
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin. BMC cancer 23 (1) (2023)
Takeshi Kawakami, Toshiki Masuishi, Yasuyuki Kawamoto, Hirofumi Go, Kyoko Kato, Ryosuke Kumanishi, Kentaro Sawada, Satoshi Yuki, Kouji Yamamoto, Yoshito Komatsu, Kei Muro, Kunihiro Fushiki, Hiromichi Shirasu, Kentaro Yamazaki
The survival benefit of increasing the number of active drugs for metastatic colorectal cancer: A multicenter retrospective study. Cancer medicine 11 (11) (2022)
Takeshi Kawakami, Junki Mizusawa, Hiroko Hasegawa, Hiroshi Imazeki, Kazuki Kano, Yuya Sato, Satoru Iwasa, Shuji Takiguchi, Yukinori Kurokawa, Yuichiro Doki, Narikazu Boku, Takaki Yoshikawa, Masanori Terashima
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 25 (6) (2022)